The cruel part of many ASX penny stocks is that the story can improve while your ownership gets worse. A company finds a project, signs a partner, drills a target, or talks up a pathway to production. Then the shares on issue keep climbing. Retail holders look at the same business months later and wonder why the price has gone nowhere despite all the progress.
That is dilution. It is not always bad. A raise that funds a value-creating acquisition or a serious drilling campaign can be the right move. But repeated dilution at lower prices can quietly destroy returns. Before buying a penny stock, your job is to ask a blunt question: how likely is it that this company needs to print more shares soon, and on what terms?
Follow the money before following the story
Start with the quarterly cash report. Penny stocks often live from raise to raise, so cash runway matters more than the long-term presentation. Take cash at quarter end and compare it with net cash used in operating and investing activities. If a company has A$2.4 million cash and spent A$900,000 during the quarter, it has less than three quarters of simple runway. If the next quarter’s planned exploration spend is A$1.3 million, the window may be shorter.
Now compare that runway with the company’s promised work program. If management is promoting a multi-rig drilling campaign, feasibility work, metallurgical testing, or overseas expansion, the current cash balance may not cover the ambition. That gap usually gets filled with new shares, options, convertible notes, project-level funding, asset sales, or a combination. Equity is often the easiest and quickest choice, especially for companies without revenue.
Suppose a company has 850 million shares on issue at 1.8 cents, implying a market cap of A$15.3 million. It also has 300 million options at 2.5 cents, 120 million performance rights tied to project milestones, and a A$2 million convertible note that can convert at a discount to the market price. If good news pushes the stock to 3 cents, the options may become relevant. If the price falls, the convertible note may convert into more shares than investors expected. Either way, the clean-looking headline market cap is not the whole picture.
The raise cadence tells you what management does under pressure
Historical behaviour matters. Open the company’s announcements and search for placements, share purchase plans, entitlement offers, cleansing notices, Appendix 2A filings, and notices of issue of securities. You are not just counting raises. You are looking for cadence and price. A company that raised at 6 cents, then 4 cents, then 2.2 cents within eighteen months has already shown you how it funds itself when expectations slip.
Convertible notes deserve special caution in penny stocks. The phrase non-dilutive funding is sometimes used loosely in market commentary, but convertibles are often dilution delayed, not dilution avoided. Check the conversion price, discount, maturity date, interest rate, security, and whether the lender receives options. A note that converts at a 20 percent discount to a future raise can become painful if the share price falls before conversion.
Director behaviour is another early warning. Directors do not control every funding outcome, but their trades can show whether they are increasing or reducing exposure while shareholders face dilution risk. A director selling into liquidity after promotional news is not proof of a bad raise coming, but it belongs in the risk file. A board that keeps buying through placements or on market after raises may be sharing more of the pain. To see whether selling is isolated or part of a broader pattern, investors often compare recent filings through insider trading disclosures alongside the company’s capital-raising history.
Here is a practical scenario. A gold explorer trades at 2.4 cents and has 1.1 billion shares on issue. It reports A$3.1 million cash, A$1.2 million quarterly cash burn, and planned next-quarter spending of A$1.5 million. It has 250 million options exercisable at 3 cents and raised twice in the past year, first at 4 cents and then at 2.8 cents. One director bought A$15,000 in the last placement, but another sold A$80,000 on market three months earlier after a drilling update. None of this means the company is uninvestable. It does mean you should model another raise before assuming upside belongs fully to today’s holders.
Use a simple dilution stress test
Before buying, run a stress test. Ask what happens if the company raises enough cash for twelve months at a 15 percent discount to the current price, with one option for every two new shares. If the share count rises by 25 percent, your upside target should be adjusted. If the company would need to raise an amount equal to half its market cap, the investment case is heavily dependent on funding terms.
The contrarian point is simple: the best penny stock research often starts with the boring capital table, not the exciting project map. If the company has enough cash, few overhanging securities, supportive directors, and a clean record of raising only when it can add value, risk becomes more manageable. If the company is short of cash, loaded with options, carrying convertibles, and issuing paper after every rally, the next announcement may not be the one you want. It may be the one that reminds you ownership is the asset you are actually buying.
Do this before the trading halt, not after it. Once a company announces a discounted raise, your choices shrink quickly. The warning signs are usually visible earlier in the cash balance, the option table, the convertibles, and the way insiders behave around liquidity events. If those signs point the wrong way, demand a wider margin of safety or avoid the raise-risk trade altogether. Preservation of ownership is part of the return calculation, not a side issue. Always matters.